Interestingly, the Aβ42 peptide, the most amyloidogenic Aβ species, is a potent competitive inhibitor of cathepsin D, which may impair the degradation of pathological forms of tau and promote tauopathy in AD [67,68]. Here, MAPT is linked to Alzheimer disease.